Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1953 1
1955 2
1956 1
1957 7
1958 1
1960 1
1961 11
1962 15
1963 11
1964 19
1965 21
1966 20
1967 18
1968 22
1969 29
1970 23
1971 35
1972 17
1973 36
1974 36
1975 47
1976 57
1977 57
1978 55
1979 47
1980 58
1981 75
1982 88
1983 83
1984 121
1985 103
1986 100
1987 115
1988 113
1989 167
1990 146
1991 127
1992 143
1993 170
1994 165
1995 191
1996 181
1997 223
1998 245
1999 203
2000 218
2001 180
2002 238
2003 244
2004 241
2005 260
2006 263
2007 243
2008 242
2009 267
2010 261
2011 285
2012 285
2013 303
2014 327
2015 294
2016 325
2017 343
2018 347
2019 327
2020 416
2021 460
2022 287
Text availability
Article attribute
Article type
Publication date

Search Results

9,328 results
Results by year
Filters applied: . Clear all
Page 1
Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity.
Mahadevan NR, Knelson EH, Wolff JO, Vajdi A, Saigí M, Campisi M, Hong D, Thai TC, Piel B, Han S, Reinhold BB, Duke-Cohan JS, Poitras MJ, Taus LJ, Lizotte PH, Portell A, Quadros V, Santucci AD, Murayama T, Cañadas I, Kitajima S, Akitsu A, Fridrikh M, Watanabe H, Reardon B, Gokhale PC, Paweletz CP, Awad MM, Van Allen EM, Lako A, Wang XT, Chen B, Hong F, Sholl LM, Tolstorukov MY, Pfaff K, Jänne PA, Gjini E, Edwards R, Rodig S, Reinherz EL, Oser MG, Barbie DA. Mahadevan NR, et al. Among authors: watanabe h. Cancer Discov. 2021 Aug;11(8):1952-1969. doi: 10.1158/2159-8290.CD-20-0913. Epub 2021 Mar 11. Cancer Discov. 2021. PMID: 33707236 Free PMC article.
In Response.
Tokumine J, Watanabe H, Moriyama K, Tabuchi S, Motoyasu A, Kageyama E, Yorozu T. Tokumine J, et al. Among authors: watanabe h. A A Pract. 2021 Jul 12;15(7):e01498. doi: 10.1213/XAA.0000000000001498. A A Pract. 2021. PMID: 34251357 No abstract available.
P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials.
Valgimigli M, Gragnano F, Branca M, Franzone A, Baber U, Jang Y, Kimura T, Hahn JY, Zhao Q, Windecker S, Gibson CM, Kim BK, Watanabe H, Song YB, Zhu Y, Vranckx P, Mehta S, Hong SJ, Ando K, Gwon HC, Serruys PW, Dangas GD, McFadden EP, Angiolillo DJ, Heg D, Jüni P, Mehran R. Valgimigli M, et al. Among authors: watanabe h. BMJ. 2021 Jun 16;373:n1332. doi: 10.1136/bmj.n1332. BMJ. 2021. PMID: 34135011 Free PMC article.
Upregulation of FGF9 in Lung Adenocarcinoma Transdifferentiation to Small Cell Lung Cancer.
Ishioka K, Yasuda H, Hamamoto J, Terai H, Emoto K, Kim TJ, Hirose S, Kamatani T, Mimaki S, Arai D, Ohgino K, Tani T, Masuzawa K, Manabe T, Shinozaki T, Mitsuishi A, Ebisudani T, Fukushima T, Ozaki M, Ikemura S, Kawada I, Naoki K, Nakamura M, Ohtsuka T, Asamura H, Tsuchihara K, Hayashi Y, Hegab AE, Kobayashi SS, Kohno T, Watanabe H, Ornitz DM, Betsuyaku T, Soejima K, Fukunaga K. Ishioka K, et al. Among authors: watanabe h. Cancer Res. 2021 Jul 15;81(14):3916-3929. doi: 10.1158/0008-5472.CAN-20-4048. Epub 2021 Jun 3. Cancer Res. 2021. PMID: 34083250
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome: The STOPDAPT-2 ACS Randomized Clinical Trial.
Watanabe H, Morimoto T, Natsuaki M, Yamamoto K, Obayashi Y, Ogita M, Suwa S, Isawa T, Domei T, Yamaji K, Tatsushima S, Watanabe H, Ohya M, Tokuyama H, Tada T, Sakamoto H, Mori H, Suzuki H, Nishikura T, Wakabayashi K, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Morino Y, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 ACS Investigators. Watanabe H, et al. JAMA Cardiol. 2022 Apr 1;7(4):407-417. doi: 10.1001/jamacardio.2021.5244. JAMA Cardiol. 2022. PMID: 35234821 Clinical Trial.
[Preface].
Tsutsui M, Watanabe H. Tsutsui M, et al. Among authors: watanabe h. Nihon Yakurigaku Zasshi. 2022;157(4):213. doi: 10.1254/fpj.22030. Nihon Yakurigaku Zasshi. 2022. PMID: 35781446 Japanese. No abstract available.
Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD).
Corte TJ, Lancaster L, Swigris JJ, Maher TM, Goldin JG, Palmer SM, Suda T, Ogura T, Minnich A, Zhan X, Tirucherai GS, Elpers B, Xiao H, Watanabe H, Smith RA, Charles ED, Fischer A. Corte TJ, et al. Among authors: watanabe h. BMJ Open Respir Res. 2021 Dec;8(1):e001026. doi: 10.1136/bmjresp-2021-001026. BMJ Open Respir Res. 2021. PMID: 34969771 Free PMC article. Clinical Trial.
Chitosan-based enzyme ink for screen-printed bioanodes.
Shitanda I, Oda K, Loew N, Watanabe H, Itagaki M, Tsujimura S, Zebda A. Shitanda I, et al. Among authors: watanabe h. RSC Adv. 2021 Jun 8;11(33):20550-20556. doi: 10.1039/d1ra03277a. eCollection 2021 Jun 3. RSC Adv. 2021. PMID: 35479878 Free PMC article.
9,328 results